News for Healthier Living
Phylex Vaccine On Track To Combat Deadly NIPAH Virus With Positive Results Of Immunogenicity Study
Phylex Biosciences has achieved positive results with its new mRNA nanoparticle vaccine against the Nipah virus in an immunogenicity study conducted in collaboration with scientists of the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
August 6, 2024
September 9 2024September 8 2024September 7 2024September 6 2024September 5 2024September 4 2024September 3 2024September 2 2024September 1 2024August 31 2024August 30 2024August 29 2024August 28 2024August 27 2024August 26 2024
|
|
|
|
|